Effects of Balance Training in Individuals With Glaucoma
Glaucoma is a chronic progressive eye disease characterized by visual field loss, which may adversely affect postural control, functional mobility, and increase the risk and fear of falling. This randomized controlled trial aims to investigate the effects of balance training on balance performance, fall risk, and fear of falling in individuals with glaucoma. Participants will be randomly assigned to either a balance training group or a control group. The intervention group will participate in a structured balance…
Conditions studied
Glaucoma
About this study
Glaucoma is a chronic progressive eye disease characterized by visual field loss, which may adversely affect postural control, functional mobility, and increase the risk and fear of falling. This randomized controlled trial aims to investigate the effects of balance training on balance performance, fall risk, and fear of falling in individuals with glaucoma. Participants will be randomly assigned to either a balance training group or a control group. The intervention group will participate in a structured balance training program for eight weeks, while the control group will continue their routine medical care. Balance performance, functional mobility/fall risk, and fear of falling will be assessed using the Berg Balance Scale, Timed Up and Go Test, and Falls Efficacy Scale-Internatio
Interventions
- Behavioral: Balance Training Program — Participants allocated to the intervention group will participate in a structured balance training program for 8 weeks, three days per week, with each session lasting approximately 45 minutes. The program will include static and dynamic balance exercises, such as tandem stance, single-leg stance, tandem walking, heel-to-toe walking, directional changes, sit-to-stand exercises, and progressive postural control activities. Exercise difficulty will be progressively increased according to each participant's functional capacity and tolerance. All exercise sessions will be performed under supervision, with appropriate safety precautions to minimize the risk of falls. Participants will continue their routine glaucoma treatment throughout the study.
Primary outcomes
- Change in Balance Performance Assessed by the Berg Balance Scale (Baseline and 8 weeks)
Eligibility information
Study locations
- Kanuni Sultan Suleyman Education and Research Hospital, Küçükçekmece, Istanbul 34307 Turkey (Türkiye)
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-11-19.